CROs can make “enormous leap” with adaptive operations

By Nick Taylor

- Last updated on GMT

Related tags Clinical trial

An “enormous leap in productivity” can be achieved by applying the principles of adaptive trials to broader operations, such as recruitment, according to a CEO that thinks CROs have to adopt the method.

Speaking to Outsourcing-Pharma, Michael Rosenberg, CEO of Health Decisions, said that adaptive operations can make a 10 to 40 per cent improvement in cost timelines.

These savings are achieved by collecting information and adapting your practices in response. For instance, by tracking where money is being spent on recruitment and what mediums are working the process can be improved after it has started.

By using this methodology Rosenberg claims that Health Decisions enrols 76 per cent of trials on or ahead of time. In July 2008 Maura Musciacco, author of Online Patient Recruitment Strategies - Optimizing the clinical trial process​, said the industry average is around 10 per cent.

Despite these advantages Rosenberg said that contract research organisations (CROs) have been slow to adopt the methods. He attributed this to the lack of technology available for capturing the information, which is vital to performing adaptive operations.

Electronic data capture (EDC) systems are generally unsuitable for the task and Rosenberg thinks they must evolve to collect operational data and make it easily available to the user.

This is important for CROs, according to Rosenberg who expects that companies will have to adopt adaptive operations. He believes that when market conditions were favourable CROs and pharmas did not consider using adaptive operations, especially given the technological barrier.

Furthermore, technology has been used by the industry to speed up old processes instead of changing the way tasks are preformed. However, Rosenberg expects the economic downturn and difficulties facing the industry to be the catalyst for change.

Solving the technology problem

To get around the lack of suitable technology Health Decisions developed its own. This includes web EDC but a digital pen is more effective, according to Rosenberg.

When the pen is used to fill in a form the data is transmitted to Health Decisions. Rosenberg claims that this system is faster, easier and more accurate the EDC.

By using these methods Health Decisions has achieved strong growth over the past few years. This slowed down in the past year but Rosenberg said the situation is improving and that the advantages Health Decisions offer are particularly desirable in the current market.

Related news

Show more

Related products

show more

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Automated metadata management in clinical trials

Automated metadata management in clinical trials

Content provided by Formedix | 01-Aug-2023 | White Paper

When it comes to efficient clinical study build, content is king. Most importantly: metadata content. In this blog, we explore the role of metadata in...

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

Related suppliers

Follow us


View more